Molecular Medicine Reports · 2024 · 30 citations · 77 references
MedicineCell BiologyPathobiologyCell SignalingImmunopathologyInflammationAntifibrotic TherapyChronic Liver DiseaseFibrosisHepatic FibrosisHepatic PathologyHepatic PathophysiologyFibrosis Resolution MechanismsHepatic Endothelial FenestrationHepatic Sinusoidal EndotheliumInflammation-driven Fibrosis ResolutionLiver Fibrosis ProgressionLiver Sinusoidal Endothelial DysfunctionSinusoidal Endothelial Cell FunctionSinusoidal Endothelial Function
Liver fibrosis due to viral or metabolic chronic liver diseases is a major challenge of global health. It is a critical pre‑stage condition of severe hepatopathy, characterized by excessive accumulation of extracellular matrix components and ongoing chronic inflammation. To date, early prevention of liver fibrosis remains challenging. As the most abundant non‑parenchymal hepatic cell population, liver sinusoidal endothelial cells (LSECs) are stabilizers that maintain the intrahepatic environment. Notably, LSECs dysfunction appears to be implicated in the progression of liver fibrosis via numerous mechanisms. Following sustained liver injury, they lose their fenestrae (cytoplasmic pores) and change their crosstalk with other cellular interactions in the hepatic blood environment. LSEC‑targeted therapy has shown promising effects on fibrosis resolution, opening up new opportunities for anti‑fibrotic therapy. In light of this, the present study summarized changes in LSECs during liver fibrosis and their interactions with hepatic milieu, as well as possible therapeutic approaches that specially target LSECs.
77
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray, Judith E. Allen, Subhra K. Biswas et al. · Immunity · 2014 · 6.2K citations · Full text
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Bi‐Sen Ding, Zhongwei Cao, Raphaël Lis et al. · Nature · 2013 · 620 citations · Full text